ATE524174T1 - Einsatz von yessotoxin bei der behandlung allergischer und asthmatischer leiden - Google Patents

Einsatz von yessotoxin bei der behandlung allergischer und asthmatischer leiden

Info

Publication number
ATE524174T1
ATE524174T1 AT07017631T AT07017631T ATE524174T1 AT E524174 T1 ATE524174 T1 AT E524174T1 AT 07017631 T AT07017631 T AT 07017631T AT 07017631 T AT07017631 T AT 07017631T AT E524174 T1 ATE524174 T1 AT E524174T1
Authority
AT
Austria
Prior art keywords
allergic
treatment
yessotoxin
asthmatic
activation
Prior art date
Application number
AT07017631T
Other languages
English (en)
Inventor
Lopez Luis Miguel Botana
Rancano Amparo Alfonso
Vieytes Mercedes Rodriguez
Garcia Maria Isabel Loza
Original Assignee
Cifga S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cifga S A Lab filed Critical Cifga S A Lab
Application granted granted Critical
Publication of ATE524174T1 publication Critical patent/ATE524174T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07017631T 2003-07-25 2004-07-21 Einsatz von yessotoxin bei der behandlung allergischer und asthmatischer leiden ATE524174T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200301773A ES2235611B2 (es) 2003-07-25 2003-07-25 Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.

Publications (1)

Publication Number Publication Date
ATE524174T1 true ATE524174T1 (de) 2011-09-15

Family

ID=34112518

Family Applications (3)

Application Number Title Priority Date Filing Date
AT04742071T ATE393833T1 (de) 2003-07-25 2004-07-21 Quantitatives verfahren zum nachweis von yessotoxinen in fischprodukten auf grundlage der durch das toxin verursachten aktivierung zellulärer phosphodiesterase
AT07017630T ATE514423T1 (de) 2003-07-25 2004-07-21 Therapeutische verwendung von yessotoxin als wachstumshemmer für humane tumorzellen
AT07017631T ATE524174T1 (de) 2003-07-25 2004-07-21 Einsatz von yessotoxin bei der behandlung allergischer und asthmatischer leiden

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT04742071T ATE393833T1 (de) 2003-07-25 2004-07-21 Quantitatives verfahren zum nachweis von yessotoxinen in fischprodukten auf grundlage der durch das toxin verursachten aktivierung zellulärer phosphodiesterase
AT07017630T ATE514423T1 (de) 2003-07-25 2004-07-21 Therapeutische verwendung von yessotoxin als wachstumshemmer für humane tumorzellen

Country Status (12)

Country Link
US (1) US20110065138A1 (de)
EP (3) EP1875906B1 (de)
JP (2) JP2006528483A (de)
CN (1) CN1852988A (de)
AT (3) ATE393833T1 (de)
AU (3) AU2004260895A1 (de)
BR (1) BRPI0412832A (de)
CA (1) CA2533600A1 (de)
DE (1) DE602004013446D1 (de)
ES (4) ES2235611B2 (de)
RU (1) RU2389488C2 (de)
WO (1) WO2005012543A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101382531B (zh) * 2008-10-08 2011-12-28 天津商业大学 利用电子鼻检测虾新鲜度的方法
ES2393696B2 (es) * 2012-09-07 2013-06-04 Universidade De Santiago De Compostela Uso de la Yessotoxina y sus derivados para el tratamiento de gliomas
CN105198900A (zh) * 2015-09-22 2015-12-30 国家海洋环境检测中心 虾夷扇贝毒素ytx纯品的提取、制备方法
US10890573B2 (en) 2017-12-19 2021-01-12 International Business Machines Corporation Facile methods to detect toxin in seafood
RU2716233C1 (ru) * 2018-11-13 2020-03-10 Федеральное государственное бюджетное учреждение науки "Федеральный исследовательский центр питания, биотехнологии и безопасности пищи" Способ количественного определения йессотоксинов в моллюсках

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672509A (en) * 1993-08-25 1997-09-30 Pfizer Inc. hPDE IV-C: a human phosphodiesterase IV isozyme
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
WO1999035283A1 (en) * 1997-12-15 1999-07-15 Beth Israel Deaconess Medical Center Methods and reagents for modulating cell motility
RU2136278C1 (ru) * 1998-04-07 1999-09-10 Государственный научный центр вирусологии и биотехнологии "Вектор" Противоопухолевое средство
WO2001072297A1 (en) * 2000-03-27 2001-10-04 The Scripps Research Institute Methods for inhibiting angiogenesis and tumor growth
IT1318605B1 (it) 2000-06-30 2003-08-27 Uni Degli Studi Di Modena E Re Procedimoento per il dosaggio di tossine dsp del gruppo delledinophysitossine e delle yessottossine.
US6977155B2 (en) * 2000-08-10 2005-12-20 Corning Incorporated Arrays of biological membranes and methods and use thereof
AR033680A1 (es) * 2000-08-30 2004-01-07 Schering Corp Compuestos triciclicos utiles como inhibidores de la farnesil proteino transferasa y su uso para la manufactura de medicamentos como agentes antitumorales
EP1251181A1 (de) * 2001-04-20 2002-10-23 Warner-Lambert Company Nicht-rekombinante Zelllinien fähig zur überwiegende Expression der Subtyp B der zyklisch Nukleotide Phosphodiesterase (PDE4) und ihre Verwendung zum Screenen von PDE4 Subtyp-spezifische Modulatoren

Also Published As

Publication number Publication date
ES2259266A1 (es) 2006-09-16
ES2235611A1 (es) 2005-07-01
BRPI0412832A (pt) 2006-11-21
EP1875907B1 (de) 2011-09-14
ES2368872T3 (es) 2011-11-23
ES2259894B2 (es) 2008-11-16
RU2389488C2 (ru) 2010-05-20
ES2259266B2 (es) 2008-06-01
DE602004013446D1 (de) 2008-06-12
AU2010202232A1 (en) 2010-07-08
EP1875906A2 (de) 2008-01-09
EP1647599B1 (de) 2008-04-30
CA2533600A1 (en) 2005-02-10
EP1875907A2 (de) 2008-01-09
ATE393833T1 (de) 2008-05-15
EP1647599A2 (de) 2006-04-19
ES2235611B2 (es) 2006-07-16
EP1875906A3 (de) 2008-02-27
EP1875907A3 (de) 2008-02-27
RU2006101631A (ru) 2006-08-27
AU2004260895A1 (en) 2005-02-10
CN1852988A (zh) 2006-10-25
ES2259894A1 (es) 2006-10-16
WO2005012543A3 (es) 2005-03-17
EP1875906B1 (de) 2011-06-29
US20110065138A1 (en) 2011-03-17
WO2005012543A2 (es) 2005-02-10
AU2010202237A1 (en) 2010-06-24
JP2006528483A (ja) 2006-12-21
ATE514423T1 (de) 2011-07-15
JP2006325580A (ja) 2006-12-07

Similar Documents

Publication Publication Date Title
BR0314059A (pt) Compostos heterocìclicos
EA200700488A1 (ru) S-ТРИАЗОЛИЛ-α-МЕРКАПТОАЦЕТАНИЛИДЫ КАК ИНГИБИТОРЫ ОБРАТНОЙ ТРАНСКРИПТАЗЫ ВИЧ
DE60217152D1 (de) Knochen-morphogene proteine (bmp), bmp-rezeptoren und bmp-bindungsproteine und ihre verwendung bei der diagnose und behandlung des glaukoms
NL300933I2 (nl) Letermovir
BRPI0512916A (pt) derivado de tienopirazol tendo atividade inibidora de pde 7
AR073348A1 (es) Inhibidores ciclicos de 11 beta-hidroxiesteroide deshidrogenasa 1
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
DE60222931D1 (de) Pyrazolopyrimidinonderivate mit pde7-hemmender wirkung
ATE439837T1 (de) 5-gliedrige heterocyclische p-38 inhibitoren
DE60233140D1 (de) Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
ATE494904T1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
EA200802054A1 (ru) Ингибиторы фермента
NO20063761L (no) Sulfonamidderivater for behandling av sykdommer
CY1109763T1 (el) Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
NO20051503L (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
AR040928A1 (es) Compuestos de acidos sulfona-hidroxamicos aromaticos, composiciones farmaceuticas y su uso en la preparacion de medicamentos utiles como inhibidores de proteasas
DE60219614D1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
DE60220385D1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
ATE524174T1 (de) Einsatz von yessotoxin bei der behandlung allergischer und asthmatischer leiden
ATE464895T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
WO2007053495A3 (en) Compounds useful as antagonists of ccr2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties